APA

Meng H., Mai W. X., Zhang H., Xue M., Xia T., Lin S., Wang X., Zhao Y., Ji Z., Zink J. I. & Nel A. E. (20130822). Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. : ACS nano.

Chicago

Meng Huan, Mai Wilson X, Zhang Haiyuan, Xue Min, Xia Tian, Lin Sijie, Wang Xiang, Zhao Yang, Ji Zhaoxia, Zink Jeffrey I and Nel Andre E. 20130822. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. : ACS nano.

Harvard

Meng H., Mai W. X., Zhang H., Xue M., Xia T., Lin S., Wang X., Zhao Y., Ji Z., Zink J. I. and Nel A. E. (20130822). Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. : ACS nano.

MLA

Meng Huan, Mai Wilson X, Zhang Haiyuan, Xue Min, Xia Tian, Lin Sijie, Wang Xiang, Zhao Yang, Ji Zhaoxia, Zink Jeffrey I and Nel Andre E. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. : ACS nano. 20130822.